2025 ANZFFR Annual Report
The second Australian and New Zealand Fragility Fracture Registry Annual Report represents a significant milestone in our understanding of fragility fracture care across both countries. Building upon the groundbreaking foundation established in our inaugural report, this comprehensive analysis demonstrates substantial progress in implementing Fracture Liaison Services (FLS) and provides unprecedented insights into care quality and patient outcomes. This report marks a pivotal moment in the registry's evolution, transitioning from baseline data collection to meaningful trend analysis and evidence-based improvement recommendations.
The depth and breadth of data now available - spanning over 15,000 patient records with robust follow-up information - enables sophisticated analysis of care effectiveness, patient trajectories, and system-wide impact. The findings presented represent not just statistical achievements, but real improvements in the lives of thousands of patients across Australia and New Zealand. Through systematic data collection and rigorous analysis, we can now demonstrate tangible evidence of enhanced care coordination, improved clinical outcomes, and more effective secondary fracture prevention strategies, validating the registry's fundamental premise that systematic measurement drives meaningful improvements in patient care.
Reporting Period: July 2023 - June 2024 (with follow-up to October 2024)
Key Highlights:
- Patient Recruitment: Data from over 15,000 people recruited to the Registry in New Zealand
- Longitudinal Follow-up: First-time reporting on 52-week follow-up outcomes, providing crucial insights into long-term patient trajectories
- Care Quality Assessment: Comprehensive analysis of FLS effectiveness across participating sites
- Standards Benchmarking: Performance measurement against Clinical Standards for FLS in New Zealand
- International Collaboration: Comparison data with Australian registry counterparts
- Geographic Coverage: Representation from hospitals across New Zealand's diverse regions
- Clinical Outcomes: Analysis of secondary fracture prevention effectiveness
- Patient Experience: Integration of patient-reported outcome measures
Major Findings:
- Improved Care Pathways: Significant enhancement in patient pathway efficiency since registry inception
- FLS Implementation: Expanded FLS coverage with improved adherence to clinical standards
- Medication Initiation: Increased rates of appropriate bone protection therapy prescription
- Follow-up Compliance: Enhanced patient engagement in long-term monitoring programs
- Equity Analysis: Identification of care disparities across different population groups and regions
- International Benchmarking: Performance comparison with global fragility fracture registries